Novartis AG
IMIDAZOLEPYRIDINE COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: ##STR00001## wherein A, R.sup.3, R.sup.4, R.sup.6, and R.sup.7 are as defined herein.
Status:
Application
Type:
Utility
Filling date:
9 Jun 2017
Issue date:
1 Aug 2019